1063 related articles for article (PubMed ID: 19827443)
1. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
[No Abstract] [Full Text] [Related]
2. [Acute episode].
Schölmerich J;
Z Gastroenterol; 2003 Jan; 41(1):27-30. PubMed ID: 12541170
[No Abstract] [Full Text] [Related]
3. [Maintaining a remission].
Fleig WE;
Z Gastroenterol; 2003 Jan; 41(1):36-42. PubMed ID: 12541172
[No Abstract] [Full Text] [Related]
4. [Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
Bischoff A
MMW Fortschr Med; 2010 Jan; 152(1-2):20. PubMed ID: 20302159
[No Abstract] [Full Text] [Related]
5. [Therapeutic principles for chronic inflammatory bowel disease].
Binder V; Munkholm P
Ugeskr Laeger; 2001 Jan; 163(1):16-21. PubMed ID: 11586666
[TBL] [Abstract][Full Text] [Related]
6. [Chronic inflammatory bowel diseases. Update on evidence-based therapy].
MMW Fortschr Med; 2005 Apr; 147(17):58-9. PubMed ID: 15903063
[No Abstract] [Full Text] [Related]
7. [New research results give hope. Causal therapy of Crohn disease in sight].
MMW Fortschr Med; 2004 Apr; 146(14):42-3. PubMed ID: 15344754
[No Abstract] [Full Text] [Related]
8. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Feagan BG; Sandborn WJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
[TBL] [Abstract][Full Text] [Related]
9. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
Sutherland LR
CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Crohn's disease].
Beglinger Ch
Ther Umsch; 2003 Mar; 60(3):159-63. PubMed ID: 12693319
[TBL] [Abstract][Full Text] [Related]
11. [Mesalazine in ulcerative colitis. Fewer cases of colorectal carcinoma].
MMW Fortschr Med; 2002 Feb; 144(9):51. PubMed ID: 11921656
[No Abstract] [Full Text] [Related]
12. [Drug treatment of Crohn's disease].
van Deventer SJ; Tytgat GN
Ned Tijdschr Geneeskd; 1998 May; 142(21):1191-5. PubMed ID: 9627451
[TBL] [Abstract][Full Text] [Related]
13. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
14. [Ulcerative colitis. Acute episode].
Reissmann A; Bischoff SC; Fleig W
Z Gastroenterol; 2004 Sep; 42(9):994-8. PubMed ID: 15455271
[No Abstract] [Full Text] [Related]
15. [Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].
Vetter C
MMW Fortschr Med; 2005 Mar; 147(13):10. PubMed ID: 15832752
[No Abstract] [Full Text] [Related]
16. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
[No Abstract] [Full Text] [Related]
17. [Therapy of chronic inflammatory bowel diseases].
Beglinger C
Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
[TBL] [Abstract][Full Text] [Related]
18. [New therapeutic data in inflammatory colitis].
Karsenti P
Ann Gastroenterol Hepatol (Paris); 1996; 32(1):10. PubMed ID: 8669802
[No Abstract] [Full Text] [Related]
19. [Ulcerative colitis. Maintenance therapy].
Kruis W; Schreiber S
Z Gastroenterol; 2004 Sep; 42(9):1011-4. PubMed ID: 15455275
[No Abstract] [Full Text] [Related]
20. Medical treatment of inflammatory bowel disease.
Singhal A; Kar P
J Assoc Physicians India; 1995 Sep; 43(9):627-31. PubMed ID: 8773067
[No Abstract] [Full Text] [Related]
[Next] [New Search]
